Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Dose Escalation Study of TriN2755 in Advanced Solid Tumors and Sarcomas
- First Posted Date
- 2010-12-14
- Last Posted Date
- 2011-06-08
- Lead Sponsor
- Trin Therapeutics GmbH
- Target Recruit Count
- 48
- Registration Number
- NCT01259518
- Locations
- 🇩🇪
Department of Internal Medicine West German Cancer Centre University Hospital Essen, Essen, Germany
News
No news found